Bresch said the drug pricing model in the U.S. has to change, but offers few suggestions as to how.
Latest posts by Market Watch (see all)
- Citigroup focus of federal probe into foreign hiring practices - February 24, 2017
- Data-analytics company Alteryx files for initial public offering - February 24, 2017
- Tesla's Deepak Ahuja to earn $500,000 a year as CFO - February 24, 2017